ArticleHeart rhythm O22025
Characterizing the recurrence of atrial arrhythmia following macro-reentrant atrial tachycardia ablation in adult patients with repaired tetralogy of Fallot.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The recurrence of arrhythmia following catheter ablation of macro-reentrant atrial tachycardia (MRAT) in repaired tetralogy of Fallot (rTOF) is poorly understood. Objective: To better describe the incidence, mechanisms, and predictors of recurrent atrial arrhythmia following MRAT ablation in rTOF. Methods: Patients with rTOF ≥18 years of age who underwent radiofrequency ablation for MRAT (typical/cavotricuspid isthmus-dependent atrial flutter, incisional/scar-mediated MRAT, upper and lower-loop reentry, or left atrial MRAT) at Duke University Hospital from 1996 to 2023 were identified. The primary outcome examined was the first recurrence of atrial arrhythmia (MRAT, atrial fibrillation, or focal atrial tachycardia) lasting ≥30 seconds, captured on a 12-lead electrocardiogram, ambulatory monitor, or electrophysiologic study. Predictors of outcome were identified using Cox regression and Kaplan-Meier survival analyses. Results: Among 58 patients who met inclusion criteria, 39 (67.2%) developed the primary outcome over an average follow-up of 5.4 ± 5.5 years. Nine patients (15.5%) underwent repeat (second or third) ablation for recurrence of an index MRAT that was targeted during the initial ablation. Right atrial (RA) area (hazard ratio 1.60 per 10 cm Conclusion: Following MRAT ablation in rTOF, recurrence of atrial arrhythmia is common and often of distinct mechanism. RA size and the presence of other atrial arrhythmia at ablation may predict recurrence. Extended courses of post-ablation anti-coagulation may prove beneficial in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.